On the 10th anniversary of World Orphan Drug Congress USA we are building the most comprehensive program and inclusive gathering of rare disease stakeholders ever!
Unfortunately, the global spread of COVID-19 has made it unsafe for us to meet physically in 2020 — but we still pledge to bring together leading industry, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers virtuallywho rely on World Orphan Drug Congress USA to meet, brainstorm and dialogue on ways to advance orphan drug development and improve access to life-saving therapies.
Over 1,500 attendees from 50+ countries will join us online August 24-26 at the 2020 edition of World Orphan Drug Congress USA!
Our conference has also become the industry defining meeting on Advanced Therapies for rare diseases, featuring discussions on clinical development, manufacturing and commercialization of cell and gene therapies, as well the annual gathering for artificial intelligence and digital health solutions transforming the rare disease industry!
CLINICAL DEVELOPMENT/ REGULATORY
RARE DISEASE ADVOCACY WORLD
GLOBAL PATIENT AND MARKET ACCESS
PRICING & REIMBURSEMENT
ADVANCED THERAPIES CLINICAL DEVELOPMENT
ADVANCED THERAPIES MANUFACTURING
ADVANCED THERAPIES COMMERCIALIZATION (NEW)
DIGITAL HEALTH AND ARTIFICIAL INTELLIGENCE (NEW)
PITCH & PARTNER